Koers Zhejiang Haisen Pharmaceutical Co., Ltd.
Aandelen
001367
CNE1000061L9
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,22 CNY | +1,83% | +11,07% | -17,61% |
Omzet 2022 | 423 mln. 58,4 mln. 54,48 mln. | Omzet 2023 | 397 mln. 54,9 mln. 51,22 mln. | Marktkapitalisatie | 2,99 mld. 413 mln. 385 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 108 mln. 14,92 mln. 13,92 mln. | Nettowinst (verlies) 2023 | 105 mln. 14,5 mln. 13,53 mln. | EV/omzet 2022 * | - |
Nettoliquiditeiten 2022 | 246 mln. 34,04 mln. 31,75 mln. | Nettoliquiditeiten 2023 | 944 mln. 130 mln. 122 mln. | EV/omzet 2023 | 5,15 x |
K/w-verhouding 2022 * |
-
| K/w-verhouding 2023 |
26,2
x | Werknemers | 563 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 24,1% |
1 dag | +1,83% | ||
1 week | +11,07% | ||
Lopende maand | +8,28% | ||
1 maand | +8,28% | ||
3 maanden | -6,41% | ||
6 maanden | -17,06% | ||
Lopend jaar | -17,61% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lin Ai
CEO | Chief Executive Officer | 63 | 01-07-11 |
Ai Juan Pan
DFI | Director of Finance/CFO | 62 | 01-02-98 |
Chuang Fan Wei
CHM | Chairman | 65 | 01-03-98 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gang Zheng
BRD | Director/Board Member | 49 | 28-09-20 |
Gui Rong Fang
BRD | Director/Board Member | 48 | 28-09-20 |
Wen Tao Dai
BRD | Director/Board Member | 53 | 28-09-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
29-04-24 | 36,22 | +1,83% | 895 291 |
26-04-24 | 35,57 | +1,48% | 1 095 028 |
25-04-24 | 35,05 | +3,42% | 1 637 220 |
24-04-24 | 33,89 | +0,12% | 682 283 |
23-04-24 | 33,85 | +3,80% | 1 046 730 |
slotkoers Shenzhen S.E., 29 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-17,61% | 340 mln. | |
+26,47% | 664 mld. | |
+29,92% | 567 mld. | |
-6,33% | 354 mld. | |
+19,35% | 330 mld. | |
+4,23% | 286 mld. | |
+14,30% | 234 mld. | |
+4,96% | 199 mld. | |
-10,10% | 196 mld. | |
-4,04% | 148 mld. |